This week Jonathan is joined by Joshua Zeidner, Associate Professor of Medicine, University of North Carolina School of Medicine, USA. Together, they discuss findings from recent research and treatment options for acute myeloid leukaemia and myelodysplastic syndrome.
Timestamps:
(00:00)- Introduction
(01:57)- Joshua’s love for the New York Giants
(04:28)- Treatment outcomes in IDH1 and IDH2-mutated acute myeloid leukaemia (AML)
(08:05)- Safety and efficacy of new agents in AML
(17:00)- Treatments for patients with AML with a TP53 mutation
(22:02)- Reliance on transfusion in myelodysplastic syndrome (MDS)
(25:44)- The time from research lab to bedside in drugs to treat AML and MDS
(30:50)- Joshua’s three wishes for healthcare
(35:13)- Outro